Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 8, 2000

View Archived Issues

Arpida Raises $23M In 2nd Round To Fund Antimicrobial Programs

SynGenix Follows Glaxo Deal With Plan For Funding Round

Meristem Aquarius Sedaherb, Adds New Plant Technologies

MMI Group Raises $5M, Plans To Increase Incubation Services

Farmers, Grain Traders Add To EU Debate On GM Organisms

Affymetrix Gains Favorable UK Ruling In Oxford Gene Conflict

Correction (Article Updated in Database)

Cantab Shares Rebound On Talk Of Potential Merger, Acquisition

NSW University Developing Anti-Angiogenesis Compound

Environmentalists Want Biotech Held Liable For Illicit GM Foods

Israeli Firm Ventures Overseas, Leads $13M IDM Investment

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....